GoHearing Ultra vs MDHearing Volt

The GoHearing Ultra is a budget-priced behind-the-ear OTC hearing aid that earns a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable price tier of the OTC market, though its overall sound performance ranks #58 of 65 devices in its category. In our testing, the Ultra shows a distinctive performance profile with significant strengths and weaknesses. Feedback handling is excellent at 5.0/5, scoring 0.46 points above the category average—users can expect stable operation without whistling during typical wear. Music streaming quality is also a genuine strength at 3.6/5, performing 1.68 points above average, making it notably better for phone audio than most OTC devices. However, speech clarity scores reveal meaningful limitations. Speech in quiet environments measured just 1.0/5, which is 1.79 points below the category average and low in absolute terms. Speech in noise similarly scored 1.0/5, falling 0.48 points below average. Own-voice comfort rated 1.9/5, also below the category norm. These results suggest the Ultra may struggle to deliver the speech audibility improvements that many users prioritize. The GoHearing Ultra may suit budget-conscious consumers who primarily want reliable streaming audio and feedback-free operation, and who have modest expectations for speech enhancement. However, several competitors in the same price range—including the Elehear Beyond and Apple AirPods Pro 2—deliver substantially stronger overall sound performance. Users prioritizing speech clarity should consider these alternatives despite similar pricing.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.